Concepedia

Sean Caenepeel

SC

Statistics

Publications

31

Citations

2.6K

H-Index

24

Active since

1998

Affiliations

Amgen (United States)(Current)

Loyola University Chicago

Cancer Research And Biostatistics

Université Bourgogne Franche-Comté

Sean Caenepeel is an author at Amgen (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1998–2025

31

Publications

31

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies

Sean Caenepeel, Sean P. Brown, Brian Belmontes et al. · Cancer Discovery · 2018 · 408 citations · Full text

The DNA sequence and biology of human chromosome 19

Jane Grimwood, Laurie Gordon, Anne S. Olsen et al. · Nature · 2004 · 359 citations · Full text

, , +6

The mouse kinome: Discovery and comparative genomics of all mouse protein kinases

Sean Caenepeel, Glen Charydczak, Sucha Sudarsanam et al. · Proceedings of the National Academy of Sciences · 2004 · 307 citations · Full text

AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer

Michael J. Giffin, Keegan S. Cooke, Edward K. Lobenhofer et al. · Clinical Cancer Research · 2020 · 220 citations · Full text

Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody

Angela Coxon, James Bready, Hosung Min et al. · Molecular Cancer Therapeutics · 2010 · 148 citations · Full text

, , +13

1–5 of 31